Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa: Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falciparum Malaria

被引:25
作者
Maire, Nicolas [1 ,2 ]
Shillcutt, Samuel D. [3 ]
Walker, Damian G. [3 ,4 ]
Tediosi, Fabrizio [5 ]
Smith, Thomas A. [1 ,2 ]
机构
[1] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4051 Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Bill & Melinda Gates Fdn, Seattle, WA USA
[5] Univ Bocconi, Milan, Italy
关键词
cost-effectiveness; expected value of perfect information; malaria; probabilistic sensitivity analysis; vaccine; ARTEMETHER-LUMEFANTRINE; COMBINATION THERAPY; EPIDEMIOLOGIC MODEL; INOCULATION RATE; HEALTH-CARE; TANZANIA; INFECTION; ADHERENCE; TRIAL; SURVEILLANCE;
D O I
10.1016/j.jval.2011.06.004
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: To evaluate the cost-effectiveness of introducing the RTS, S malaria vaccine into the Expanded Programme on Immunization (EPI) in Sub-Saharan Africa (SSA), the contributions of different sources of uncertainty, and the associated expected value of perfect information (EVPI). Methods: Vaccination was simulated in populations of 100,000 people at 10 different entomological inoculation rates (EIRs), using an existing stochastic model and a 10-year time horizon. Incremental cost-effectiveness ratios (ICERs) and EVPI were computed from weighted averages of outputs using two different assignments of the EIR distribution in 2007. Uncertainty was evaluated by resampling of epidemiological, vaccination, and health systems model parameters. Results: Health benefits were predicted consistently only at low transmission, and program costs always substantially exceeded case management savings. Optimal cost-effectiveness was at EIR of about 10 infectious bites per annum (ibpa). Main contributors to ICER uncertainty were uncertainty in transmission intensity, price per vaccine dose, decay rate of the vaccine effect, degree of homogeneity in host response, and some epidemiological model parameters. Other health system costs were unimportant. With a ceiling ratio of 207 international dollars per disability-adjusted life-year averted, 52.4% of parameterizations predicted cost-effectiveness in the primary analysis. Conclusions: Cost-effectiveness of RTS, S will be maximal in low endemicity settings (EIR 2-20 ibpa). Widespread deployment of other transmission-reducing interventions will thus improve cost-effectiveness, suggesting a selective introduction strategy. EVPI is substantial. Accrual of up-to-date information on local endemicity to guide deployment decisions would be highly efficient.
引用
收藏
页码:1028 / 1038
页数:11
相关论文
共 77 条
[1]  
ADAM T, 2004, ANAL REPORT COSTS IM
[2]  
Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8
[3]   Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites [J].
Ajayi, Ikeoluwapo O. ;
Browne, Edmund N. ;
Garshong, Bertha ;
Bateganya, Fred ;
Yusuf, Bidemi ;
Agyei-Baffour, Peter ;
Doamekpor, Leticia ;
Balyeku, Andrew ;
Munguti, Kaendi ;
Cousens, Simon ;
Pagnoni, Franco .
MALARIA JOURNAL, 2008, 7 (1)
[4]   Malaria misdiagnosis: effects on the poor and vulnerable [J].
Amexo, M ;
Tolhurst, R ;
Barnish, G ;
Bates, I .
LANCET, 2004, 364 (9448) :1896-1898
[5]   Disability-adjusted life years: a critical review [J].
Anand, S ;
Hanson, K .
JOURNAL OF HEALTH ECONOMICS, 1997, 16 (06) :685-702
[6]  
[Anonymous], 2006, Global burden of disease and risk factor
[7]  
[Anonymous], 2008, WORLD MAL REP 2008
[8]  
[Anonymous], CURR MAL SIT TRENDS
[9]  
[Anonymous], 2009, ALLIANCE HLTH POLICY
[10]   The development of the RTS,S malaria vaccine candidate: challenges and lessons [J].
Ballou, W. R. .
PARASITE IMMUNOLOGY, 2009, 31 (09) :492-500